Biomineralization of Bi2S3-Gd2O3 nanocomposites: a novel approach for enhanced photothermal and MRI applications

In this study, Bi2S3-Gd2O3 nanocomposites (Bi2S3-Gd2O3@BSA) were prepared via biomineralization using albumin as a template, and the nanomaterials were directed to the tumor site through surface folic acid modification. Among these materials, Bi2S3 serves as an effective photothermal conversion agen...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Digest Journal of Nanomaterials and Biostructures 2024-12, Vol.19 (4), p.1903-1920
Hauptverfasser: Lu, Q., Zhang, B. H., Yi, T. H., Hao, L. G., Xue, J. L., Duan, W. B., Wan, Y. G., Chen, D. T., Wang, J., Guo, X., Zhang, L. P.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:In this study, Bi2S3-Gd2O3 nanocomposites (Bi2S3-Gd2O3@BSA) were prepared via biomineralization using albumin as a template, and the nanomaterials were directed to the tumor site through surface folic acid modification. Among these materials, Bi2S3 serves as an effective photothermal conversion agent (PTA) for photothermal therapy at tumor sites, attributed to its impressive photothermal conversion efficiency. In contrast, Gd2O3, being a paramagnetic substance, can serve effectively as a contrast agent in the magnetic resonance imaging (MRI). According to in vitro and in vivo experiments, the nanomaterials exhibit low toxicity, favorable biocompatibility, and outstanding photothermal properties. Upon the exposure to 808 nm laser irradiation, the nanomaterials quickly reach the therapeutic temperature necessary for effective tumor treatment. With folic acid modification, these nanomaterials accumulate in the tumor region, enabling efficient treatment. This strategy provides a fresh outlook for the purposeful design of diagnostic agents aimed at tumor imaging and therapy.
ISSN:1842-3582
1842-3582
DOI:10.15251/DJNB.2024.194.1903